About Contact Us Careers

Antiretroviral Protease Inhibitors Market - Top Companies and Manufacturers

Request Free Sample Copy

Report ID: 2553
Published Date: Oct 14, 2024
Report Format: PDF, PPT

Buy Now

Companies Dominating the Anti-retroviral Protease Inhibitors Landscape

Janssen Pharmaceuticals Company Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Boehringer Ingelheim Pharmaceuticals, Inc.
Thermo Fisher Scientific Inc.
Sigma-Aldrich, Inc.
CYTOSKELETON, INC.
Merck & Co., Inc.
Genentech, Inc.
AbbVie Inc.
Tibotec Pharmaceuticals
Bristol-Myers Squibb Company

Browse Key Market Insights with Data Illustration:

Anti-retroviral Protease Inhibitors Market Size & Share, Growth Report 2036

In the News

April 2020 — San Diego Supercomputer Center (SDSC) researchers reported that they have created a pharmacophore model and conducted data mining of the conformational database of FDA-approved drugs. These drugs are known to identify 64 compounds as potential inhibitors of the COVID-19 protease.

Author Credits: Radhika Pawar

Report ID: 2553
Published Date: Oct 14, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Anti-retroviral Protease Inhibitors Market size is poised to grow at substantial growth rate during the forecast period i.e., between 2024-2036.

North America industry is anticipated to hold largest revenue share by 2036, propelled by increasing cases of HIV and chronic HCV, growing industrial sector, and advanced health care infrastructure in the region.

The major players in the market are Janssen Pharmaceuticals Company Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Thermo Fisher Scientific Inc., Sigma-Aldrich, Inc., CYTOSKELETON, INC., Merck & Co., Inc., Genentech, Inc., AbbVie Inc., Tibotec Pharmaceuticals, Bristol-Myers Squibb Company, and others.

Inquiry Before Buying Request Free Sample